Stock Chart
IMNM
Type: SELL wallstreet
Strike: $32
Premium: $5.80
Expiry: Jan 15, 2027
Target: $36
Score: -39
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About IMNM - Immunome, Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current …
Key Statistics
More IMNM Analysis
This IMNM stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track IMNM's price movements with trendlines, gamma walls, and key support/resistance levels.